首页 › 基金 › Ophir Asset Management Pty Ltd › MRVI

Ophir Asset Management Pty Ltd 对 MRVI 的持仓历史

MARAVAI LIFESCIENCES HLDGS I · 医疗保健

Ophir Asset Management Pty Ltd 在 Q2 2026 的 13F 申报中披露持有 MRVI(MARAVAI LIFESCIENCES HLDGS I)4,826,698 股,市值约 US$30.1M,约占其申报组合的 2.48%,在其申报持仓中市值排名第 20 位。 Ophir Asset Management Pty Ltd 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)4.83M 股
申报持仓市值$30.12M
组合权重2.48%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Ophir Asset Management Pty Ltd 对 MRVI 的持仓演变

Ophir Asset Management Pty Ltd 于 Q2 2026 首次披露 MRVI 持仓:4,826,698 股(约 US$30.1M)。

逐季持仓明细

季度股数金额变化
Q2 2026 4.83M $30.12M 新进

关于 MRVI 与 13F 数据

MRVI(MARAVAI LIFESCIENCES HLDGS I)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 MRVI,申报仓位最大的包括:GTCR LLC (US$125.7M), BRAIDWELL LP (US$54.3M), 12 West Capital Management LP (US$44.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MRVI 的基金

查看 MRVI 的全部基金持有人 →

常见问题

How long has Ophir Asset Management Pty Ltd held MRVI?

Ophir Asset Management Pty Ltd has disclosed MRVI holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Ophir Asset Management Pty Ltd's current position in MRVI?

As of Q2 2026, Ophir Asset Management Pty Ltd holds 4.83M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $30.12M, representing 2.48% of its reported portfolio and ranking #20.

Has Ophir Asset Management Pty Ltd been buying or selling MRVI?

In the latest 13F filing (Q2 2026), Ophir Asset Management Pty Ltd newly opened its position in MRVI.

Which other funds hold MRVI?

Other major institutional holders of MRVI include GTCR LLC, BRAIDWELL LP, 12 West Capital Management LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.